Use of PSA nadir to predict subsequent biochemical outcome following external beam radiation therapy for T1-2 adenocarcinoma of the prostate
Zietman, A.L., Tibbs, M.K., Dallow, K.C., Smith, C.T., Althausen, A.F., Zlotecki, R.A., Shipley, W.U.
Published in Radiotherapy and oncology (01.08.1996)
Published in Radiotherapy and oncology (01.08.1996)
Get full text
Journal Article
1013 Time to second prostate specific antigen (PSA) failure is a surrogate endpoint for prostate cancer death in prospective trials of therapy for localized disease
Zietman, A.L., Dallow, K.C., Shipley, W.U., Haney, N.M., McManus, P.L.
Published in International journal of radiation oncology, biology, physics (1995)
Published in International journal of radiation oncology, biology, physics (1995)
Get full text
Journal Article
2018 Selective bladder preservation by combined modality therapy for invasive bladder cancer
Kachnic, L.A., Kaufman, D.S., Zietman, A.L., Dallow, K.C., Griffin, P.P., Heney, N.M., Althausen, A.F., Shipley, W.U.
Published in International journal of radiation oncology, biology, physics (1995)
Published in International journal of radiation oncology, biology, physics (1995)
Get full text
Journal Article
7 Adjuvant and salvage irradiation following radical prostatectomy for prostate cancer
Morris, M.M., Dallow, K.C., Zietman, A.L., Althausen, A.F., Heney, N.M., McGovern, F.J., Shipley, W.U.
Published in International journal of radiation oncology, biology, physics (1995)
Published in International journal of radiation oncology, biology, physics (1995)
Get full text
Journal Article
1016 Biochemical outcome following external beain radiation therapy for T1–2 prostate carcinoma: the importance of achieving an undetectable nadir PSA
Tibbs, M.K., Zietmant, A.L., Dallow, K.C., Althausenz, A.F., Heney, N.M., Shipley, W.U.
Published in International journal of radiation oncology, biology, physics (1995)
Published in International journal of radiation oncology, biology, physics (1995)
Get full text
Journal Article